Rapid Nutrition Outlines 2023 Company Roadmap
London, United Kingdom 8 Feb. 2023 - Rapid Nutrition PLC (Euronext Growth: ALRPD), a natural wellness company focused on organic wholefood-based nutrition and science-based herbal products with growing worldwide distribution, outlines its growth strategy for the year ahead as well as key company updates.
In 2022, the company bolstered the foundations of the business by securing strong investor support to pay down its long-term debts, in addition to successfully completing the strategic acquisition of The Plant-Based Bundle –with more than 100,000 customers. Continued expansion of its IP portfolio included the acceptance of its flagship brand trademark in China, a key focus market for the company in 2023; further, Rapid Nutrition made notable progress on its new Azurene formula and updated the flagship SystemLS weight loss brand, which is currently being manufactured.
“Our diligent management team has continued to expand and is successfully executing on its growth strategy by continuing to progress into new markets while strengthening the core fundamentals of the business by distinguishing long-term debt and adding additional revenue streams,” said Rapid Nutrition CEO Simon St. Ledger. “We know that market fluctuations have been challenging but are very optimistic about the opportunities in front of us.”
As announced in December, Rapid Nutrition has entered into a non-binding letter of intent to acquire FFS, subject to due diligence. This phase, with a brief pause for the holidays, is in its final stage with the outcome anticipated in the coming weeks. Azurene was anticipated to hit the market late Q4 2022, however, due to manufacturing capacities, it is expected to reach the market in the first half of 2023 in time for the northern hemisphere winter. This timeline provided the company the opportunity to finalise branding and packaging for this unique formula, and SystemLS is in production with its long-term manufacturer with a new look and line extensions, capitalising on the latest consumer trends, are expected to be available in the first or second quarter.
Company management is collaborating with current and potential partners to expand market presence in focus markets, chiefly the UK, Europe and China in 2023. China’s health and wellness industry, valued at $683 billion, continues to explode while Europe and the UK are seeing expansions in overall health and wellness, making these locations an ideal trifecta for growth this year and beyond.
Furthermore, Rapid Nutrition continues to expand its product portfolio to capitalise on growing market trends in key categories such as weight loss, immunity, skin care, vegan and gluten-free products, and general wellness, all with an eye toward expanding distribution and pinpointing new partnerships and opportunities.
“As we continue to ramp up our growth plans, Rapid Nutrition has a lot to celebrate and even more to look forward to in the days and months to come,” St. Ledger added. “With a focus on the core business fundamentals, which will no doubt ultimately reflect on market and a vibrant industry, we believe we are in a great position for growth and success.”
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or other Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).